The Embassy of India at Jordan, Amman has informed Pharmexcil that due to the public boycott of Danish products in Jordan, following the cartoon controversy, new trade opportunities have arisen for other countries to replace Denmark as a source for several products imported by Jordan.

One major product that requires immediate replacement is insulin, which is being imported from Denmark so far. The Jordanian importers are now looking at alternative sources for insulin supply.

"The Embassy of India was advised by the Jordan Chamber of Commerce to bring this fact to the attention of manufacturers of insulin in India," said Dr PV Appaji, executive director of Pharmexcil.

Pharmexcil has for this purpose sent communication to all its members, who manufacture or export insulin to initiate discussions with the Jordan Chamber of Commerce.